VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Luzhou Laojiao Co., Ltd. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Luzhou Laojiao Co., Ltd.
000568.SZ · Shenzhen Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Luzhou Laojiao Co., Ltd.'s moat claims, evidence, and risks.
View 000568.SZ analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 73 / 100 for Luzhou Laojiao Co., Ltd.).
- Segment focus: Luzhou Laojiao Co., Ltd. has 2 segments (91.5% in Mid- and high-end baijiu); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Luzhou Laojiao Co., Ltd. has 5 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Luzhou Laojiao Co., Ltd.
Mid- and high-end baijiu
Premium baijiu (strong-aroma) in China
China (primarily); limited exports
Consumers (personal consumption) and gifting/banquet channels via distributors/retail
Distiller / brand owner
91.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Luzhou Laojiao Co., Ltd. strengths
Sanofi strengths
Segment mix
Luzhou Laojiao Co., Ltd. segments
Full profile >Mid- and high-end baijiu
Oligopoly
Other baijiu (mainstream/value)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.